The Pitt and ER are similar enough for Michael Crichton’s widow’s lawsuit to proceed, court rules

When three judges on the California Court of Appeal issued a unanimous opinion on Wednesday, the legal fog around HBO Max’s medical drama “The Pitt” lifted just enough to reveal the stakes. The court said the new series shares “clear and numerous similarities” with Michael Crichton’s landmark show “ER”—the same emergency‑room setting, rapid‑fire medical jargon, graphic injuries and a freshly‑minted, inept resident. That finding satisfies the prima facie threshold required for Sherri Crichton, the late author’s widow, to press her claim before a Los Angeles jury.

The heart of the dispute lies in a 1994 “frozen‑rights” clause that Crichton negotiated for “ER.” The provision locked any spin‑off, sequel or reboot behind his written consent, a safeguard meant to prevent the franchise from being reshaped without the creator’s blessing. Television (WBTV) launched “The Pitt” in early 2025, the estate argued the show was nothing but an “ER” reboot renamed after negotiations for a proper revival fell apart. The appellate court rejected WBTV’s attempt to dismiss the case under California’s anti‑SLAPP statute, affirming that the estate’s evidence met the low bar for a derivative‑work claim.

The decision also trimmed the lawsuit’s target list. While the studio remains liable, the court found no proof that key figures—actor‑producer Noah Wyle, veteran showrunner John Wells and writer‑producer R. Their dismissal as defendants underscores a legal nuance: liability can attach to the corporate owner of the intellectual property even when individual creators are unaware of contractual constraints.

Beyond the courtroom, the ruling could reverberate through Hollywood’s contract drafts. If a jury later upholds the estate’s claim, “frozen‑rights” clauses may gain enforcement teeth, forcing studios to seek explicit clearances before re‑imagining any long‑running series. Conversely, a verdict for WBTV could signal that thematic overlaps—setting, pace, medical jargon—are insufficient to prove infringement, giving creators broader latitude to explore genre conventions without fear of legacy claims. The case also spotlights the anti‑SLAPP law’s limits; the court’s refusal to toss the suit suggests that claims rooted in contract breaches, not merely free‑speech concerns, survive heightened scrutiny.

“I am deeply gratified,” said Sherri Crichton in a statement, underscoring how personal the battle feels for the estate. With discovery now underway, both sides will exchange scripts, production notes and internal emails that could reveal just how far “The Pitt” diverged—or converged—from Crichton’s original vision. The next legal milestone: a jury trial that could begin as early as next summer, unless the parties settle, a prospect the studio deems unlikely given the “significant friction” described by legal observers. Whatever the outcome, the case will likely become a benchmark for how legacy contracts are interpreted in an era of endless reboots and streaming‑driven revivals.